Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2002
06/20/2002WO2002048392A2 Screening method for inhibitors of pyruvate orthophosphate dikinase
06/20/2002WO2002048390A2 Methods and kits for detecting protein kinases
06/20/2002WO2002048388A2 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell
06/20/2002WO2002048387A2 System and method for predicting chromosomal regions that control phenotypic traits
06/20/2002WO2002048385A2 Compositions and methods for the release of nucleic acid molecules from solid matrices
06/20/2002WO2002048375A2 Purified active hcv ns2/3 protease
06/20/2002WO2002048370A2 Compositions and methods relating to colon specific genes and proteins
06/20/2002WO2002048368A2 Proteins associated with cell growth, differentiation, and death
06/20/2002WO2002048366A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/20/2002WO2002048365A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/20/2002WO2002048363A2 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof
06/20/2002WO2002048358A2 Regulation of human chemokine-like receptor
06/20/2002WO2002048352A1 Method of analyzing gene expression
06/20/2002WO2002048351A2 A method for in vitro molecular evolution of protein function
06/20/2002WO2002048347A1 Molecule correspondent to genotype and phenotype, composing elements thereof, method of producing the corespondent molecule and method of using the same
06/20/2002WO2002048337A2 Secreted human proteins
06/20/2002WO2002048334A2 P450rai-2 (p450 cytochrome 26b), encoding nucleic acid molecules and methods and uses thereof
06/20/2002WO2002048333A2 Novel human kinases and uses thereof
06/20/2002WO2002048321A2 Use of acetyl-coa carboxylase for identifying compounds that have an insecticidal effect
06/20/2002WO2002048316A1 Method for in vitro culture of ovarian follicles
06/20/2002WO2002048188A1 Plasmodium aldolase polypeptides and nucleic acids
06/20/2002WO2002048182A2 Interferon-alpha induced gene
06/20/2002WO2002048167A1 Method for generating immortal dendritic cell lines
06/20/2002WO2002047711A2 Modulators of activity of g-protein-coupled receptor kinases
06/20/2002WO2002047610A2 Marine actinomycete taxon for drug and fermentation product dicovery
06/20/2002WO2002047535A2 High throughput assay to detect inhibitors of the map kinase pathway
06/20/2002WO2002047534A2 Compositions and methods for the therapy and diagnosis of lung cancer
06/20/2002WO2002034110A3 Method of determining global coagulability and hemostatic potential
06/20/2002WO2002031185A8 Method of identifying abnormal immune reactions
06/20/2002WO2002029089A9 Haplotypes of the htatip gene
06/20/2002WO2002026764A3 Haplotypes of the ccr6 gene
06/20/2002WO2002022856A3 Uses of the mammalian ccl18 and related reagents
06/20/2002WO2002002580A3 Haplotypes of the etfb gene
06/20/2002WO2002002000A3 Methods of screening for alzheimer's disease
06/20/2002WO2002000711A3 Ev-vegf nucleic acids and polypeptides and methods of use
06/20/2002WO2002000232A3 Methods and compositions for developing spore display systems for medicinal and industrial applications
06/20/2002WO2001098542A3 Universal collection medium
06/20/2002WO2001098475A3 Method for the detection of cathepsins, asparaginyl endopeptidases and isozymes thereof and leukocystatin
06/20/2002WO2001094541A3 Human mesenchymal progenitor cell
06/20/2002WO2001092876A3 Method for identifying compounds for modulating the activity of a tumour suppressor protein
06/20/2002WO2001090152A3 Compositions and methods for the therapy and diagnosis of breast cancer
06/20/2002WO2001088104A3 Neural progenitor cell populations
06/20/2002WO2001085950A3 Genes of the 1-desoxy-d-xylulose biosynthesis path
06/20/2002WO2001085942A3 Cytoskeleton-associated proteins
06/20/2002WO2001085941A3 Myc targets
06/20/2002WO2001085096A3 Mast cell regulation
06/20/2002WO2001083793A3 Targeted modification of chromatin structure
06/20/2002WO2001083524A3 Rna metabolism proteins
06/20/2002WO2001077379A3 A method of cell detection
06/20/2002WO2001077374A3 Method for identifying and isolating genome fragments with linkage disequilibrium
06/20/2002WO2001077164A3 Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis
06/20/2002WO2001075098A3 33166, a human hydrolase-like molecule and uses thereof
06/20/2002WO2001074904A3 G-protein coupled receptors and nucleic acids encoding same
06/20/2002WO2001074897A3 Protein amf-1 to amf-10 and nucleic acids encoding the same
06/20/2002WO2001073086A3 Method for genetically modifying a plant
06/20/2002WO2001073050A3 3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor
06/20/2002WO2001072830A3 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
06/20/2002WO2001069230A3 Methods and apparatus for the location and concentration of polar analytes using an alternating electric field
06/20/2002WO2001068851A3 Polypeptides and nucleic acids encoding same
06/20/2002WO2001060857A3 Compositions useful for regulating parkin gene activity
06/20/2002WO2001053487A3 Human sperm specific lysozyme-like proteins
06/20/2002WO2001051671A3 Methods for identifying inhibitors of neuronal degeneration
06/20/2002WO2001051669A3 Nucleic acid binding assay and selection method
06/20/2002WO2001051633A3 Compositions and methods for the therapy and diagnosis of prostate cancer
06/20/2002WO2001048236A9 METHODS FOR IDENTIFYING AGENTS CAPABLE OF MODULATING PROTEIN KINASE C THETA (PKCυ) ACTIVITY
06/20/2002WO2001044445A8 Human lyases and associated proteins
06/20/2002WO2001025479A3 Fluorescent multiplex-sequencing
06/20/2002WO2001006001A3 Dna for detecting changes in chromosome 8
06/20/2002WO2000079285A3 Devices and methods for the performance of miniaturized homogeneous assays
06/20/2002WO2000077245A9 Cell-based assay for screening cox-2 inhibitors
06/20/2002WO2000075333A9 Streptavidin expressed gene fusions and methods of use thereof
06/20/2002WO2000061750A9 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS
06/20/2002WO2000061596A8 50 human secreted proteins
06/20/2002WO2000060126A3 Quantitative assay for expression of genes in microarray
06/20/2002WO2000052210A9 Methods for targeting rna molecules
06/20/2002WO2000050596A9 14273 receptor, a novel g-protein coupled receptor
06/20/2002US20020078473 Pesticides
06/20/2002US20020077756 Neural-network-based identification, and application, of genomic information practically relevant to diverse biological and sociological problems, including drug dosage estimation
06/20/2002US20020077754 Pharmacophore fingerprinting in primary library design
06/20/2002US20020077470 Cardiac muscle-associated genes
06/20/2002US20020077468 Corticotropin-releasing factor2 receptors
06/20/2002US20020077465 Nuceotide sequences coding enzymatic polypeptide for use in the treatment and prevention of inflammation, cancer, muuscle disorders and thrombosis
06/20/2002US20020077460 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
06/20/2002US20020077459 Enhanced protein thermostability and temperature resistance
06/20/2002US20020077458 Nucleotide sequences for use in the diagnosis, treatment and prevention of apoptosis defects
06/20/2002US20020077455 Protease inhibitors
06/20/2002US20020077309 For diagnosis, prognosis, evaluation of therapies and treatment of pancreatic disorders
06/20/2002US20020077297 Disposing cell comprising sodium channel blocker into a well, disposing fluorescent dye into well; adding sodium channel blocker, to be identified, into well; passing stimulating current to generate an action potential; optically measuring
06/20/2002US20020077296 High-throughput screening method
06/20/2002US20020077295 For therapy of cranial or cerebral trauma, spinal cord injury, stroke or a demyelinating disease
06/20/2002US20020077293 Methods and compositions for the treatment of inflammatory diseases
06/20/2002US20020077283 Blocking interaction of caveolin with a protein in vivo by administering peptide which comprises caveolin scaffolding domain
06/20/2002US20020077273 Methods of using agents that modulate bone formation and inhibit adipogenesis
06/20/2002US20020077270 Nucleic acids, proteins, and antibodies
06/20/2002US20020076823 Near infrared chemiluminescent acridinium compounds and uses thereof
06/20/2002US20020076813 Stabilizing diluent for polypeptides and antigens
06/20/2002US20020076805 Appartus for use in accurate analysis and detection of preferential particles in sample
06/20/2002US20020076796 2786, a novel human aminopeptidase
06/20/2002US20020076795 Novel TRF1 binding protein, methods of use thereof
06/20/2002US20020076793 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4
1 ... 2286 2287 2288 2289 2290 2291 2292 2293 2294 2295 2296 2297 2298 2299 2300 2301 2302 2303 2304 2305 2306 ... 3003